2026 NPPES data Hematology & Oncology Physician NPI 1063409688 M.D.
Verify on CMS →

MARK VELLEK, M.D.

Hematology & Oncology Physician in LAS VEGAS, Nevada. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
445
Medicare Part D claims · 157 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.1K
61 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK VELLEK, M.D. filed 445 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in LAS VEGAS, Nevada, prescribing 92% generic.

445
Part D claims, 2023
92%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK VELLEK, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

445 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

MARK VELLEK, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK VELLEK, M.D.?

Quality data not reported

NPI registry status

Active

Issued 09/29/2005

NPI 1063409688

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

445 47% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Nevada

How Hematology & Oncology Physician compares to other specialties among Nevada providers

Nevada providers

Hematology & Oncology Physician share within Nevada

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Nevada

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK VELLEK, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 3131 LA CANADA ST STE 140, LAS VEGAS, NV, 89169, with a listed phone of (702) 933-9400. NPI 1063409688 was issued on 09/29/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what VELLEK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 445 prescription claims written by this provider, covering 157 Medicare beneficiaries and totaling roughly $457K in drug spend, split 8% brand-name and 92% generic by claim count, with an opioid prescribing rate of 12.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3131 LA CANADA ST STE 140
LAS VEGAS, NV 89169

Provider Details

NPI 1063409688
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 09/29/2005

Hospital and facility affiliations

Facilities where MARK VELLEK, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MURRAY-CALLOWAY COUNTY PUBLIC HOSPITAL CORPORATION
MURRAY, KY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK VELLEK, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.1K

Largest payer

PFIZER INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

MARK VELLEK, M.D. — brand share 8.0%
Specialty average (est.)

8% brand-name claims vs 92% generic, on 445 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

445
Total Claims
$457K
Total Drug Cost
157
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
523
Total Day Supply
10,873
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$432K
Generic Drug Cost
$24K
Opioid Claims
54 (12.1% rate)

Patient Demographics

Average Patient Age
72.8 years
Avg HCC Risk Score
1.61
Gender Split
61% female / 39% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK VELLEK, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prochlorperazine Maleate
66
Ondansetron Odt
Ondansetron
63
Anastrozole
62
Dexamethasone
42
Prednisone
27
Xtandi
Enzalutamide
19
Gabapentin
18
Morphine Sulfate Er
Morphine Sulfate
16
Oxycodone Hcl
16

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How MARK VELLEK, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

MARK VELLEK, M.D.'s 445 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Nevada

Other clinicians with the same primary specialty enrolled in Nevada, drawn from the same CMS NPPES roster as VELLEK.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK VELLEK, M.D.'s specialty?
MARK VELLEK, M.D. specializes in Hematology & Oncology Physician and practices in LAS VEGAS, Nevada. Credentials: M.D..
How much does MARK VELLEK, M.D. prescribe under Medicare Part D?
In 2023, MARK VELLEK, M.D. wrote 445 Medicare Part D claims totaling $457K in drug costs for 157 beneficiaries.
Where is MARK VELLEK, M.D. located?
MARK VELLEK, M.D. is located at 3131 LA CANADA ST STE 140, LAS VEGAS, NV, 89169. Phone: (702) 933-9400.
What is MARK VELLEK, M.D.'s NPI number?
MARK VELLEK, M.D.'s National Provider Identifier (NPI) is 1063409688, issued on 09/29/2005.
Does MARK VELLEK, M.D. prescribe more brand-name or generic drugs?
MARK VELLEK, M.D.'s prescribing is 8% brand-name and 92% generic drugs by claim count, with $432K in brand drug costs.
Does MARK VELLEK, M.D. prescribe opioids?
Yes, MARK VELLEK, M.D. had 54 opioid claims in 2023 with an opioid prescribing rate of 12.1%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does MARK VELLEK, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK VELLEK, M.D.'s most frequently prescribed drugs include Prochlorperazine Maleate, Ondansetron Odt, Anastrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK VELLEK, M.D. accept Medicare?
MARK VELLEK, M.D. appears in CMS Medicare data with 445 Part D claims and 157 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK VELLEK, M.D.'s credentials?
MARK VELLEK, M.D.'s NPI is 1063409688 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology